Hepatitis C virus in elderly cancer patients
Autor: | Massimiliano Berretta, Matteo Angelo Cannizzaro, Elvira Rampello, Salvatore Ranno, Corrado Risino, Maria Pia Gargante, Marcello Romano, Tiziana Fricia, Mariano Malaguarnera, Mario Costanzo |
---|---|
Rok vydání: | 2005 |
Předmět: |
Oncology
medicine.medical_specialty biology business.industry Melanoma Hepatitis C virus Thyroid Cancer medicine.disease medicine.disease_cause digestive system diseases Lymphoma medicine.anatomical_structure Prostate Internal medicine Hepatocellular carcinoma Internal Medicine medicine biology.protein Antibody business |
Zdroj: | European journal of internal medicine. 17(5) |
ISSN: | 0953-6205 |
Popis: | There are few studies about the relationship between HCV and the development of other tumors. We consider the prevalence of HCV infection in elderly cancer patients who have tumors different from that in hepatocellular carcinoma and non-Hodgkin's lymphoma.We evaluated the prevalence of HCV infection in 236 elderly cancer patients in comparison with 300 elderly volunteers. Cancer patients presented a variety of tumors other than hepatocarcinoma and lymphoma, namely, colorectal (n=66), breast (n=44), bladder (n=40), prostate (n=30), lung (n=22), kidney (n=15), pancreatic (n=6), thyroid (n=5), cervical (n=4), melanoma (n=3) and vaginal (n=1).Among the 236 elderly cancer patients, 87 were positive for HCV antibodies (36%) and, among the 300 elderly patients, 32 were positive (10%). A comparison between the two groups revealed a statistically significant difference (p0.001) between patients with kidney cancer, bladder cancer or prostate cancer, and the control group.The high anti-HCV prevalence in elderly cancer patients may be due to several mechanisms. These patients are more prone to acquire an HCV infection because of their frequent hospitalizations and the immunological changes in patients with tumors may lower their threshold for HCV infection. |
Databáze: | OpenAIRE |
Externí odkaz: |